Alcon (ALC) EBITDA (2009 - 2026)

Alcon (ALC) posted quarterly EBITDA of $2.7 billion for Q1 2026, down 1.41% quarter-over-quarter from $2.7 billion in Q4 2025.

Alcon (ALC) EBITDA (2009 - 2026) Analysis & Trends

Alcon's EBITDA history runs 11 years deep, the most recent figure standing at $2.7 billion for Q1 2026.

In Q1 2026, EBITDA changed N/A year-over-year to $2.7 billion; the TTM figure through Mar 2026 stood at $8.2 billion (changed N/A YoY), while the FY2025 annual figure was $1.4 billion, down 3.75% from the prior year.
EBITDA for Q1 2026 stood at $2.7 billion, down from $2.7 billion in the prior quarter.
The five-year high for EBITDA was $2.7 billion in Q4 2025, with the low at -$409.0 million in Q4 2024.
The 5-year median for EBITDA is $540.0 million (2022), against an average of $842.3 million.
The sharpest annual moves came in 2024 and 2025: EBITDA plunged 176.88% in 2024, then soared 757.7% in 2025.
Alcon's EBITDA stood at $441.0 million in 2022, then advanced by 20.63% to $532.0 million in 2023, then slumped by 176.88% to -$409.0 million in 2024, then soared by 757.7% to $2.7 billion in 2025, then fell by 1.41% to $2.7 billion in 2026.
Business Quant data shows ALC's EBITDA at $2.7 billion in Q1 2026, $2.7 billion in Q4 2025, and $2.6 billion in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EBITDA (Qtr)
1	Intuitive Surgical	132.71 Bn	127.50 Bn	1.96 Bn	971.90 Mn
2	Becton Dickinson	51.57 Bn	50.71 Bn	2.32 Bn	663.00 Mn
3	Alcon	35.52 Bn	34.17 Bn	1.68 Bn	11.00 Mn
4	Resmed	33.28 Bn	31.81 Bn	861.22 Mn	448.71 Mn
5	Medline	27.86 Bn	25.18 Bn	2.22 Bn	395.00 Mn
6	West Pharmaceutical Services	25.15 Bn	24.71 Bn	329.20 Mn	179.10 Mn
7	Solventum	15.31 Bn	14.91 Bn	1.29 Bn	181.00 Mn
8	Cooper Companies	14.86 Bn	14.72 Bn	735.40 Mn	-31.00 Mn
9	Baxter International	13.63 Bn	11.48 Bn	1.03 Bn	217.00 Mn
10	Align Technology	11.37 Bn	10.27 Bn	757.43 Mn	154.01 Mn

Download Data